Recombinant human growth hormone therapy in malnourished dialysis patients:: A randomized controlled study

被引:62
作者
Iglesias, P
Díez, JJ
Fernández-Reyes, MJ
Aguilera, A
Burgués, S
Martínez-Ara, J
Miguel, JL
Gómez-Pan, A
Selgas, R
机构
[1] Labs Serono, Madrid, Spain
[2] Hosp La Paz, Dept Endocrinol, Madrid, Spain
[3] Hosp La Paz, Dept Nephrol, Madrid, Spain
关键词
growth hormone; malnutrition; anabolism; chronic renal failure; dialysis;
D O I
10.1053/ajkd.1998.v32.pm9740162
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Recombinant human growth hormone (rhGH; Saizen, Serono, Spain) has been recently used as an anabolic agent in several catabolic states, including malnourished chronic dialysis patients. However, up-to-date, comparative studies with control groups of dialysis patients have not been reported. The aim of the present study was to assess the effects of rhGH on nutritional status in a group of malnourished adult chronic dialysis patients undergoing both continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis (HD). The patients were randomly assigned to the control group (nine patients; 6 women, 3 men; mean age, 58.3 +/- 5.6 years; seven undergoing CAPD, two undergoing HD) or the rhGH group (eight patients; three women, five men; mean age, 63.9 +/- 3.1 years; four undergoing CAPD, four undergoing HD). Both groups were similar at baseline. All patients were given dietary prescriptions (35 kcal/kg/d and 1 g protein/kg ideal body weight/d) during 4 weeks. In the rhGH group, rhGH was administered at 0.2 IU/kg/d subcutaneously (SC) during this period. Anthropometric and analytic parameters were assessed before (0 weeks) therapy and at 2 and 4 weeks after starting therapy. The rhGH group showed an increase of 1.238 kg in body weight from 64.3 +/- 4.3 (mean +/- standard error of the mean [SEM]) to 65.6 +/- 4.9 kg (P < 0.05). Serum insulin-like growth factor type 1 (IGF-1) concentrations increased from 216.6 +/- 42.5 to 581.2 +/- 171.5 ng/mL (4 weeks; P < 0.01) and transferrin levels increased from 271.2 +/- 16.3 to 314.5 +/- 21.2 mg/dL (4 weeks; P < 0.05). A significant reduction in blood urea nitrogen (BUN) level was observed (62.1 +/- 1.8 v 46.8 +/- 3.8 mg/dL; 4 weeks; P < 0.05). Mean daily protein intake, determined by individual dietary survey, at 0 and 4 weeks, remained constant in both groups. In conclusion, weight gain and IGF-1 and transferrin level increases and BUN level decreases, despite the constant oral intake, suggest that short-term rhGH administration is associated with an anabolic reaction in malnourished dialysis patients. (C) 1998 by the National Kidney Foundation, Inc.
引用
收藏
页码:454 / 463
页数:10
相关论文
共 34 条
[1]  
Ahlmen Jarl, 1996, Journal of the American Society of Nephrology, V7, P1436
[2]  
BERGSTROM J, 1993, KIDENY INT S40, V43, P39
[3]   IMPORTANCE OF NUTRITION IN DIALYSIS PATIENTS [J].
BLAGG, CR .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 17 (04) :458-461
[4]  
BLAKE PG, 1995, PERITON DIALYSIS INT, V15, P210
[5]   INSULIN-LIKE GROWTH FACTOR-I STIMULATES HUMAN ERYTHROID COLONY FORMATION INVITRO [J].
CLAUSTRES, M ;
CHATELAIN, P ;
SULTAN, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (01) :78-82
[6]  
Diez JJ, 1995, NEFROLOGIA, V15, P539
[7]  
DOUGLAS RG, 1990, BRIT J SURG, V77, P758
[8]   NEW NORMS OF UPPER LIMB FAT AND MUSCLE AREAS FOR ASSESSMENT OF NUTRITIONAL-STATUS [J].
FRISANCHO, AR .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1981, 34 (11) :2540-2545
[9]   Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients [J].
Garibotto, G ;
Barreca, A ;
Russo, R ;
Sofia, A ;
Araghi, P ;
Cesarone, A ;
Malaspina, M ;
Fiorini, F ;
Minuto, F ;
Tizianello, A .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (01) :97-105
[10]   MALNUTRITION IN HEMODIALYSIS-PATIENTS [J].
HAKIM, RM ;
LEVIN, N .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (02) :125-137